adoption

Early adoption: Holy Name doctor explains how medical center is eager to implement latest noninvasive tech for liver cancer and beyond

Early adoption: Holy Name doctor explains how medical center is eager to implement latest noninvasive tech for liver cancer and beyond

admin April 20, 2024 0

Less is more today in cancer care. … And Holy Name‘s Dr. George Miller has more to say about that:...

Read More

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0

AI in Liver Care Needs Vigilance and Tailoring to Population

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0

Kidney Dialysis Equipment Market, In-Depth Analysis

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0